• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Covidien

Covidien

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Hill-Rom Elects Stacy Enxing Seng to its Board of Directors

    Hill-Rom Elects Stacy Enxing Seng to its Board of Directors

  2. Remy Durand Joins Frazier Healthcare as Senior Associate to Life Sciences Team

    Remy Durand Joins Frazier Healthcare as Senior Associate to Life Sciences Team

  3. The Reluctant Bulls of 2014

    After a few fits and starts, Tyco is now set to trade under three separate tickers starting July 2. Tyco International will retain the TYC ticker, Tyco Electronics will assume the TEL ticker, and Covidien , the health-care concern, will trade as COV . We'll have a separate analyst covering each; ...

  4. Research and Markets: U.S. & European Transcatheter Embolization Device Market 2010-2020

    Research and Markets: U.S. & European Transcatheter Embolization Device Market 2010-2020

  5. Updates, advisories and surprises

    Updates, advisories and surprises

  6. Medtronic beats profit and sales expectations

    Medtronic beats profit and sales expectations

  7. Covidien's Wide-Moat Device Business Positioned Well for Long-Term Growth

    R&D investments and a narrowed focus have widened the firm's competitive advantages.

  8. Covidien's Mallinckrodt Spin-Off Faces Challenging Environment

    Mallinckrodt's lack of scale and weak branded business keep it from earning a moat.

  9. Super-Wide Moat in the Making at Medtronic

    The device maker's planned acquisition of Covidien will make it a force to be reckoned with.

  10. Nominees for 2014 International-Stock Manager of the Year

    A tough year for foreign markets and currencies yields a compact field.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.